[Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses]

other public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

This study evaluated four risk of malignancy indices (RMI) for adnexal masses, finding that RMI2 showed superior diagnostic efficiency, though further study on optimal cutoff levels for Chinese populations is needed.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-24 · read from full text

The paper evaluates the application value of four malignancy risk indices in the preoperative assessment of patients with adnexal masses, aiming to discriminate benign versus malignant disease. Using a diagnostic-evaluation framework, it compares how the indices perform in preoperative diagnoses and analyzes their usefulness in clinical decision-making based on the risk scores. A key limitation stated or implied is that the results depend on the specific patient cohort and the available preoperative data, which may constrain generalizability to other populations or settings. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the diagnostic values of four risk of malignancy indices (RMI) for malignant adnexal masses. METHODS: The data of 223 women with adnexal masses admitted to the Department of Obstetrics and Gynecology of Peking Union Medical College Hospital for surgical exploration between June 2008 and December 2008 were retrospectively analyzed. The sensitivity, specificity, positive predictive value and negative predictive value of RMI1, RMI2, RMI3, and RMI4 in the diagnosis of malignant adnexal masses were calculated. RESULTS: When the cutoff levels of RMI1, RMI2, RMI3 were set at 200 and RMI4 at 450, the sensitivities for diagnosing malignant adnexal masses ranged 59.0%-67.2%, the specificities ranged 94.4%-96.9 %, the positive predictive values ranged 82.0%-87.8%, and the negative predictive values ranged 90.9%-92.6%. The Youdens indexes (YI) of RMI1, RMI2, RMI3, and RMI4 were 0.559,0.606,0.576, and 0.559, respectively. RMI2 was significantly different from RMI1 (P=0.000), RMI3 (P=0.008), and RMI4 (P=0.000) in terms of diagnostic efficiency. RMI1, RMI2, RMI3, and RMI4 at a cutoff level of 75.688.679.1, 177.2 respectively, according to ROC curves, yielded sensitivities of 77.8%-82.5%, specificities of 84.6%-90.1%, positive predictive values of 69.0%-75.4%, and negative predictive values of 90.9%-92.6%; the relevant YI of RMI1, RMI2, RMI3, and RMI4 were 0.635, 0.665, 0.651 and 0.705, respectively. Under this cutoff level, the difference between RMI1, RMI2, RMI3, and RMI4 in diagnosing malignancy had no statistic significant. The primary histological types arising false negative were early stage epithelial ovarian cancer and non-epithelial ovarian cancer. The primary histological types arising false positive were endometriosis masses and degenerative sex cord-stromal tumor. CONCLUSIONS: RMIs are useful indices for the differentiation between benign and malignant pelvic diseases. Meanwhile, their cutoff levels for Chinese populations need further study.
Full text 919 characters · extracted from oa-doi-fallback · click to expand
PDF(830 KB) PDF(830 KB) 四种恶性风险指数在附件肿块良恶性诊断中的应用价值 - {{javascript:window.custom_author_cn_index=0;}} - {{custom_author.name_cn}} {{custom_author.xref}} , {{javascript:window.custom_author_cn_index++;}} - {{article.zuoZhe_CN}} 作者信息 + Application Values of Four Risk of Malignancy Indices in the Preoperative Evaluation of Patients with Adnexal Masses - {{javascript:window.custom_author_en_index=0;}} - {{custom_author.name_en}} {{custom_author.xref}} , {{javascript:window.custom_author_en_index++;}} - {{article.zuoZhe_EN}} Author information + 文章历史 + {{article.keyPoints_cn}} {{article.keyPoints_en}} {{article.zhaiyao_cn}} {{article.zhaiyao_en}} 中图分类号: {{custom_clc.code}} ({{custom_clc.text}}) | {{custom_ref.label}} | {{custom_citation.content}} {{custom_citation.annotation}} | {{article.reference}} {{custom_fn.content}} {{custom_fund}} {{article.copyrightStatement_cn}} {{article.copyrightLicense_cn}} / | 〈 | 〉 |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Adnexal Diseases Risk Assessment Adnexal Diseases Adnexal Diseases Adolescent Adult Aged Aged, 80 and over CA-125 Antigen CA-125 Antigen Female Humans Menopause Middle Aged Retrospective Studies Risk Assessment Sensitivity and Specificity Ultrasonography Young Adult

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-19T06:15:14.566301+00:00
pubmed
last seen: 2026-05-13T22:17:07.008521+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine